Gene: CRMP1
Official Full Name: collapsin response mediator protein 1provided by HGNC
Gene Summary: This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38422 | CRMP1 Knockout cell line (HeLa) | Human | CRMP1 | 1:3~1:6 | Negative | Online Inquiry |
KO38423 | CRMP1 Knockout cell line (HEK293) | Human | CRMP1 | 1:3~1:6 | Negative | Online Inquiry |
KO38424 | CRMP1 Knockout cell line (A549) | Human | CRMP1 | 1:3~1:4 | Negative | Online Inquiry |
CRMP1 Gene Knockout Cell Lines are engineered cellular models that lack the expression of the Collapsin Response Mediator Protein 1 (CRMP1), a critical component in neuronal development and signaling pathways. These cell lines serve as a powerful tool for investigating the role of CRMP1 in various biological processes, including neurite outgrowth, synaptic plasticity, and neurodevelopmental disorders. By employing advanced CRISPR-Cas9 technology, these knockout cell lines allow for precise gene editing, facilitating studies on the functional consequences of CRMP1 depletion and its implications in pathological conditions.
The key mechanisms of CRMP1 involve its involvement in neuronal growth cones, where it acts as a signaling molecule that influences cytoskeletal dynamics. The disruption of CRMP1 function can lead to altered neuronal connectivity and contribute to the pathogenesis of neurodegenerative diseases. Research utilizing CRMP1 knockout models provides invaluable insights into these processes, making them indispensable in both fundamental and applied neuroscience research.
Scientifically, these cell lines hold significant promise for preclinical studies in drug development and disease modeling, particularly for conditions such as schizophrenia and autism spectrum disorders associated with synaptic dysfunction. Compared to alternative cell line models, the CRMP1 knockout variants offer unmatched specificity in studying the CRMP1 gene's functions, ensuring that researchers obtain more accurate and relevant data.
The distinct advantage of using CRMP1 Gene Knockout Cell Lines lies in their ability to provide a clearer understanding of gene function in a controlled environment, which is critical for elucidating complex biological phenomena. Researchers and clinicians can leverage these cell lines to explore novel therapeutic targets and advance their understanding of neurodevelopmental processes.
Moreover, our company is dedicated to quality and innovation in biological research tools. With our extensive experience and focused expertise in cell line development, we provide researchers with reliable and state-of-the-art products designed to drive forward scientific discovery and clinical advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.